An Aberrant Right Subclavian Artery–Esophageal Fistula—A Fatal Complication of a Common Anomaly: A Case Report and Review of Literature

Keywords

ARSA - aberrant right subclavian artery - esophageal bleeding - nasogastric tube

Introduction

An aberrant right subclavian artery (ARSA) with retroesophageal course is a common anomaly of the aortic arch.[1] Erosion of the esophagus due to pressure necrosis from prolonged indwelling objects (nasogastric tube and metallic stents), radiation therapy, esophageal carcinoma, or iatrogenic injury lead to the development of a fistula between the ARSA and the esophagus. Endovascular interventions, such as balloon occlusion, covered stent deployment, and coil embolization, can be life-saving, as hypovolemic shock precludes surgery in most patients.

Case Presentation

A 14-year-old girl was referred to a radiology department with sudden onset of massive hematemesis. She had history of quadriparesis and respiratory failure a month ago and was reverse-transcription polymerase chain reaction (RT-PCR)-positive for novel coronavirus disease 2019 (COVID-19). She had been intubated 18 days back with placement of nasogastric tube (NGT) 20 days before the hematemesis episode. Computed tomography (CT) angiography ([Fig. 1]) showed ARSA with retroesophageal course with active extravasation of contrast into the esophagus.

Fig. 1 (a) Axial and (b) sagittal CT angiography images showing the retroesophageal aberrant right subclavian artery (small arrows). Nasogastric tube (larger arrows) and tracheostomy tube with bulb (asterix) is seen in situ. There is contrast extravasation into the esophagus (curved arrows). CT, computed tomography.

The selective cannulation of ARSA was done using 5F Vert catheter (Cook Medical, Ireland) which revealed active, rapid extravasation of contrast into the esophagus, suggesting ARSA–esophageal fistula ([Fig. 2]). A plan was made to perform a balloon occlusion followed by deployment of an covered stent across defect. Unfortunately, she went into cardiopulmonary arrest and could not be revived.

Fig. 2 A digital subtraction angiogram performed in antero-posterior oblique projection showing the aberrant right subclavian artery (asterix) with arterioesophageal fistula (larger arrow) and contrast extravasation along the esophagus (curved arrows) close to nasogastric tube (arrow heads). Left subclavian artery is also visualized in same image (dashed arrow).

Discussion

The prevalence of an ARSA is 0.5 to 2% in the general population.[1] The occlusion of vasa vasorum of pressure necrosis and erosion of the esophagus lead to the formation of a fistula with the ARSA.[2] Prolonged endotracheal and/or nasogastric intubation is the most common predisposing factor for fistula formation. On literature review, we found a total of 17 cases of aberrant subclavian artery–esophageal fistula in which the prolonged endotracheal and/or nasogastric intubation has been listed as a causative factor of fistula formation[3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] ([Table 1]). The average duration between NGT and endotracheal tube (ET) placement and first episode of bleeding is of 29 (6–56) and 23 (13–31) days, respectively. In index case, NGT and ET placements were done 20 and 18 days back, respectively. The steroid use and secondary infection have also been reported as risk factors for the fistula formation.[7] The index patient did not received steroids in her course in the hospital. The COVID-19 infection has been shown to have more risk of development and rupture of pseudoaneurysms due to endothelial inflammation.[20] In few cases, initial “alarming” episodes of minimal bleeding have also been reported.[7] [9] [10] [19] [21]

Table 1 Reported cases of aberrant subclavian artery–esophageal fistula due to prolonged use of nasogastric or endotracheal tube

Sr. no.	Study (year)	Age (y)/sex	Basic disease	ET/tracheostomy duration (d)	NGT duration (d)	Proposed risk factor for fistula	Endovascular treatment	Surgical treatment/esophageal ballooning	Follow-up	Outcome
1	Livesay et al[4] (1982)	25/M	Trauma	13	7	Inflated tracheostomy balloon + NGT	None	Repaired	2 weeks	Died
2	Jungck and Püschel[5] (1983)	6/M	Trauma	28	42	Inflated tracheostomy balloon + NGT	None	Esophageal balloon Thoracotomy	Same day	Died
3	Belkin et al[6] (1984)	27/M	Right retromolar carcinoma	No	56	Prolonged NGT	None	Esophageal balloon Ligation	10 days	Died
4	Edwards et al[7] (1984)	36/F	Cerebral aneurysm	Yes/NA	27	Prolonged NGT/steroid use/secondary infection	None	None	Same day	Died
5	Gossot et at[8] (1985)	72/F	Aortic repair	30	30	Prolonged NGT/ET/secondary infection	NA	NA	NA	Died
6	Guzzetta et al[9] (1989)	4 mo/F	Congenital heart disease and its repair	28	56	Prolonged NGT	None	Ligation	14 weeks	Died
7	Ikeda et al[10] (1991)	9/M	Congenital heart disease	Yes/NA	Yes/NA	Prolonged NGT	NA	NA	NA	Died
8	Hirakata et al[11] (1991)	55/M	Esophagus carcinoma surgery	(NA)	44	Prolonged NGT, Radiation enteritis, surgical trauma	Ballooning	Ligation	NA	Survived
9	Miller et al[12] (1996)	11/F	Intraventricular bleed	14	17	Prolonged NGT/ET	None	Esophagus balloon Ligation	2 years	Survived
10	Minyard and Smith[13] (2000)	39/F	Head trauma	NA	6	NGT	None	None	6 days	Died
11	Feugier et al[14] (2003)	24/M	Polytrauma	31	31	Prolonged NGT and ET	Ballooning	Ligation	4 month	Survived
12	Chapman et al[15] (2010)	34/F	NA	Yes/NA	Yes/NA	Prolonged NGT	Ballooning	Ligation	NA	Died
13	Jain et al[16] (2012)	57/M	Scimitar syndrome	18	18	Prolonged NGT and ET	Coiling	Esophageal balloon Ligation	3 weeks	Survived
14	Oliveira et al[3] (2016)	20/M	Trauma	22	22	Prolonged NGT and ET	None	Ligation	6 weeks	Survived
15	Kudose et al[17] (2017)	20/M	VATER Status lung transplant	Yes/NA	Yes/NA	Prolonged NGT and ET	None	None	Same day	Died
16	Shires and Rohrer[18] (2018)	41/M	Pneumonia	Yes/NA	16	NGT and ET	Stenting	None	Same day	Died
17	Kim et al[19] (2021; ALSA)	63/M	Intracranial Bleed	NA	Yes/NA	NGT, biopsy	TEVAR Coiling	None	2 months	Died
18	Index case (2021)	14/F	Porphyria COVID-19 pneumonia	18	20	NGT/ET/COVID-19	None	None	Same day	Died

Abbreviations: ALSA, aberrant left subclavian artery; COVID-19, novel coronavirus disease 2019; ET, endotracheal tube; F, female; M, male; NA, data not available; NGT, nasogastric tube; VATER (VACTERL), vertebrae, anus, heart, trachea, esophagus, kidney and limbs.

ARSA can be visualized on CT angiography and can be confirmed on conventional angiography. Placement of esophageal Sengstaken–Blakemore tube can help in temporary control of bleeding.[6] Surgical options include ligation of the subclavian artery with revascularization of the right arm.[14] In endovascular approach, angioplasty balloon can be inflated across the fistulous segment as a temporary measure before the definitive surgery.[14] More recently, successful usage of covered stents as a definitive measure has been described.[18] Despite all attempts at management, the reported overall survival rate of ARSA–esophageal fistula is only 35.7%.[17] In present literature review of NGT or ET, the overall survival found to be 29.4% as a cause of the fistula formation. Out of these 17 cases, four patients died on the same day of bleeding episode.[5] [7] [17] [18] Therefore, it is very important to recognize and manage this fatal condition as soon as possible. The authors also recommend to avoid prolonged nasogastric tube placement in patient with aberrant subclavian artery.

Conclusion

The fistulization of ARSA into the esophagus is a rare and lethal complication and may be seen in patients with prolonged nasogastric or endotracheal intubation. A high index of suspicion and careful evaluation of radiological imaging is required in its timely recognition and treatment.

• References

• 1 Türkvatan A, Büyükbayraktar FG, Olçer T, Cumhur T. Congenital anomalies of the aortic arch: evaluation with the use of multidetector computed tomography. Korean J Radiol 2009; 10 (02) 176-184
• 2 Merchant FJ, Nichols RL, Bombeck CT. Unusual complication of nasogastric esophageal intubation-erosion into an aberrant right subclavian artery. J Cardiovasc Surg (Torino) 1977; 18 (02) 147-150
• 3 Oliveira E, Anastácio M, Marques A. Aberrant right subclavian artery-esophageal fistula: massive upper gastrointestinal hemorrhage secondary to prolonged intubation. Braz J Anesthesiol 2016; 66 (03) 318-320
• 4 Livesay JJ, Michals AA, Dainko EC. Anomalous right subclavian arterial esophageal fistula: an unusual complication of tracheostomy. Tex Heart Inst J 1982; 9 (01) 105-108
• 5 Jungck E, Püschel K. Erosion hemorrhage from an esophago-aortic fistula in congenital anomaly of the thoracic aorta as a fatal complication of a stomach tube [in German]. Anaesthesist 1983; 32 (10) 498-500
• 6 Belkin RI, Keller FS, Everts EC, Rösch J. Aberrant right subclavian artery–esophageal fistula: a cause of overwhelming upper gastrointestinal hemorrhage. Cardiovasc Intervent Radiol 1984; 7 (02) 87-89
• 7 Edwards BS, Edwards WD, Connolly DC, Edwards JE. Arterial-esophageal fistulae developing in patients with anomalies of the aortic arch system. Chest 1984; 86 (05) 732-735
• 8 Gossot D, Nussaume O, Kitzis M, Cohen G, Chalaux G, Andreassian B. Fatal hematemesis due to erosion of a retro-esophageal right subclavian artery by an esophagogastric tube [in French]. Presse Med 1985; 14 (31) 1655-1656
• 9 Guzzetta PC, Newman KD, Ceithaml E. Successful management of aberrant subclavian artery-esophageal fistula in an infant. Ann Thorac Surg 1989; 47 (02) 308-309
• 10 Ikeda T, Yokota Y, Ando F. et al. A case of an aberrant subclavian artery-esophageal fistula due to prolonged nasogastric intubation [in Japanese]. Kyobu Geka 1991; 44 (12) 1045-1047
• 11 Hirakata R, Hasuo K, Yasumori K, Yoshida K, Masuda K. Arterioenteric fistulae: diagnosis and treatment by angiography. Clin Radiol 1991; 43 (05) 328-330
• 12 Miller RG, Robie DK, Davis SL. et al. Survival after aberrant right subclavian artery-esophageal fistula: case report and literature review. J Vasc Surg 1996; 24 (02) 271-275
• 13 Minyard AN, Smith DM. Arterial-esophageal fistulae in patients requiring nasogastric esophageal intubation. Am J Forensic Med Pathol 2000; 21 (01) 74-78
• 14 Feugier P, Lemoine L, Gruner L, Bertin-Maghit M, Rousselet B, Chevalier JM. Arterioesophageal fistula: a rare complication of retroesophageal subclavian arteries. Ann Vasc Surg 2003; 17 (03) 302-305
• 15 Chapman JR, Sedghi S, Christie BD, Nakayama DK, Wynne JL. Aberrant right subclavian artery-esophageal fistula. Am Surg 2010; 76 (12) 1430-1432
• 16 Jain KK, Braze AJ, Shapiro MA, Perez-Tamayo RA. Aberrant right subclavian artery-esophageal fistula and severe gastrointestinal bleeding after surgical correction of scimitar syndrome. Tex Heart Inst J 2012; 39 (04) 571-574
• 17 Kudose S, Pineda J, Saito JM, Dehner LP. Aberrant right subclavian artery-esophageal fistula in 20-year-old with VATER association. J Pediatr Intensive Care 2017; 6 (02) 127-131
• 18 Shires CB, Rohrer MJ. Anomalous right subclavian artery-esophageal fistulae. Case Rep Vasc Med 2018; 2018: 7541904
• 19 Kim S, Jeon KN, Bae K. Aberrant left subclavian artery-esophageal fistula in a patient with a prolonged use of nasogastric tube: a case report and literature review. Diagnostics (Basel) 2021; 11 (02) 195
• 20 Zhang N, Lechien JR, Martinez V, Carlier R-Y, El Hajjam M. Contribution of interventional radiologist in the management of pseudoaneurysm and neck hemorrhages in COVID-19 patients. Ear Nose Throat J 2021; 100 (2_suppl): 148S-151S
• 21 Millar A, Rostom A, Rasuli P, Saloojee N. Upper gastrointestinal bleeding secondary to an aberrant right subclavian artery-esophageal fistula: a case report and review of the literature. Can J Gastroenterol 2007; 21 (06) 389-392